African iron overload
diseaseOn this page
Also known as Bantu siderosishereditary iron overload and African Americans
Summary
African iron overload (MONDO:0011012) is a disease. A subtype of hereditary hemochromatosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Phenotypes (HPO): 25
Clinical features
Signs & symptoms
Clinical features (HPO)
25 HPO clinical features (Orphanet curated; top 25 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0003281 | Increased circulating ferritin concentration | Very frequent (80-99%) |
| HP:0001395 | Hepatic fibrosis | Frequent (30-79%) |
| HP:0002614 | Hepatic periportal necrosis | Frequent (30-79%) |
| HP:0006562 | Viral hepatitis | Frequent (30-79%) |
| HP:0012115 | Hepatitis | Frequent (30-79%) |
| HP:0012463 | Elevated transferrin saturation | Frequent (30-79%) |
| HP:0012465 | Elevated hepatic iron concentration | Frequent (30-79%) |
| HP:0000078 | Abnormality of the genital system | Occasional (5-29%) |
| HP:0000819 | Diabetes mellitus | Occasional (5-29%) |
| HP:0001397 | Hepatic steatosis | Occasional (5-29%) |
| HP:0001402 | Hepatocellular carcinoma | Occasional (5-29%) |
| HP:0001413 | Micronodular cirrhosis | Occasional (5-29%) |
| HP:0001627 | Abnormal heart morphology | Occasional (5-29%) |
| HP:0001635 | Congestive heart failure | Occasional (5-29%) |
| HP:0002240 | Hepatomegaly | Occasional (5-29%) |
| HP:0003118 | Increased circulating cortisol level | Occasional (5-29%) |
| HP:0011732 | Abnormality of adrenal morphology | Occasional (5-29%) |
| HP:0011772 | Abnormality of thyroid morphology | Occasional (5-29%) |
| HP:0012090 | Abnormal pancreas morphology | Occasional (5-29%) |
| HP:0012852 | Hepatic bridging fibrosis | Occasional (5-29%) |
| HP:0031035 | Chronic infection | Occasional (5-29%) |
| HP:0100510 | Vitamin C deficiency | Occasional (5-29%) |
| HP:0000939 | Osteoporosis | Very rare (<1-4%) |
| HP:0002586 | Peritonitis | Very rare (<1-4%) |
| HP:0011459 | Esophageal carcinoma | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | African iron overload |
| Mondo ID | MONDO:0011012 |
| MeSH | C537904 |
| OMIM | 601195 |
| Orphanet | 139507 |
| DOID | DOID:0111033 |
| ICD-11 | 869212237 |
| SNOMED CT | 66576001 |
| UMLS | C0268063 |
| MedGen | 75649 |
| GARD | 0008495 |
| NORD | 740 |
| Is cancer (heuristic) | no |
Also known as: African iron overload · Bantu siderosis · hereditary iron overload and African Americans
Disease family
This is a subtype of hereditary hemochromatosis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by developmental or physiological process › metabolic disease › mineral metabolism disease › iron metabolism disease › hemosiderosis › hereditary hemochromatosis › African iron overload
Related subtypes (7): neonatal hemochromatosis, hemochromatosis type 3, hemochromatosis type 4, hemochromatosis type 5, hemochromatosis type 2, hemochromatosis type 1, digenic hemochromatosis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.